Gujarat Kidney and Super Speciality Limited (GKSPL) is a multispecialty healthcare provider primarily operating in Gujarat, India. Established initially as Vihaan Medicare Private Limited in December 2019, the company underwent several rebranding and structural changes, eventually becoming a public limited company under its current name in November 2023. GKSPL focuses on delivering secondary (surgical) and tertiary (super-specialty) medical services, including inpatient and outpatient care, diagnostic services, emergency care, and advanced surgical procedures.
The company launched its first hospital in Vadodara, Gujarat, in 2014 as Gujarat Kidney Hospital, with initial capacities of 15 beds, later expanded to 65 beds by 2018. This facility specializes in urological treatments, offering five subspecialties, including endourology and paediatric urology. Subsequent expansions included the establishment of an interventional cardiology department in 2019, the first laparoscopic radical prostatectomy in 2021, and the commencement of operations of its second hospital in Godhra, Gujarat, in 2023.
The Godhra facility marked significant milestones, such as performing its first renal transplant, angiography, and introducing retrograde intrarenal surgery (RIRS) in 2024. Moreover, Godhra Hospital is equipped with super-specialty departments for cardiology, urology, and nephrology. The company has also pursued acquisitions, including a majority stake in Raj Palmland Hospital Private Limited and Ashwini Medical Centre, expanding its healthcare network further.
With a commitment to advanced medical technology and skilled professionals, GKSPL is positioned as a key healthcare provider in the central Gujarat region. To fuel its growth and expansion, the company has filed a Draft Prospectus and plans to launch an IPO of 2.2 crore equity shares with a face value of Rs. 2 each.
